Lorazepam for the Treatment of Status Epilepticus in Children
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to gather the data to: 1) determine the best dose, and 2)
evaluate its effectiveness and safety in stopping seizures. Part 1 is a pharmacokinetic study
(study of how much drug is found in the body after it is given through a vein and how fast
the body gets rid of the drug).
Phase:
Phase 1
Details
Lead Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)